Corvus Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Corvus Pharmaceuticals, Inc.
CIK #0001626971
EDGAR Form CIK 2011 - 2025
10-K [0001626971]
10-Q [0001626971]
3 [0001626971]
4 [0001626971]
5 [0001626971]
8-K [0001626971]
D [0001626971]
SC 13D [0001626971]
SC 13G [0001626971]
Form 13D/13G Filer Form 13D/13G Subject Filed
Point72 Asset Management LP Corvus Pharmaceuticals Inc [2024-05-09]
Samlyn Capital LLC Corvus Pharmaceuticals Inc [2024-02-14]
CHI Advisors LLC Corvus Pharmaceuticals Inc [2023-02-13]
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-12-06]
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-10-22]
Venrock Healthcare Capital Partners II LP Corvus Pharmaceuticals Inc [2021-09-30]
Tang Capital Partners LP Corvus Pharmaceuticals Inc [2021-09-22]
EcoR1 Capital LLC Corvus Pharmaceuticals Inc [2021-05-11]
Price T Rowe Associates Inc /MD/ Corvus Pharmaceuticals Inc [2019-02-14]
Adams Street Partners LLC Corvus Pharmaceuticals Inc [2018-03-21]
View All
Form 3/4/5 Subject 2011 - 2025
OrbiMed Advisors LLC
Corvus Pharmaceuticals, Inc.
OrbiMed Capital GP V LLC
Thompson Peter A.
Morrison Scott W
Grais Linda
Clark Ian T
Jones William Benton
Miller Richard A MD
van den Broek Richard
View All
Terms | Privacy | Guide
tony@aum13f.com